Arak, H., and T. Kuş. “Prognostic and Predictive Significance of HER2-Low Expression in Metastatic Hormone Receptor Positive Breast Cancer Patients Receiving CDK4-6 Inhibitor Therapy”. European Journal of Therapeutics, vol. 30, no. 5, May 2024, pp. 662-74, doi:10.58600/eurjther2151.